Fidji Simo stepped down from OpenAI because her body decided to quit before she did. Medical leave in April. Full resignation now. The human machine broke down while working on the machine that pretends to be human.
She'll transition to advisor. That's the corporate equivalent of your dad saying he's not mad, just disappointed. You get to keep the email address and none of the responsibility. Perfect gig if you can land it. Most of you can't.
Chronic illness forces you to focus on recovery. Brutal way to learn that running an AI company won't fix your mortality. All those board meetings about artificial general intelligence and she got a reminder that biological general intelligence requires maintenance. The irony writes itself but I'll write it anyway because that's what they pay me for.
Retail traders who bought OpenAI-adjacent stocks thinking executive stability matters are learning a valuable lesson about how little executive stability matters. Simo joined OpenAI in March 2024. Lasted just over a year before her body said enough. That's less time than most of you held your GameStop shares and somehow even less profitable from a health perspective.
She was previously CEO of Instacart. Went from delivering groceries to delivering chatbot governance. Now she's delivering herself to doctors. Career trajectory looks like a normal distribution curve that got sick halfway through.
The advisor role means OpenAI gets to keep her brain without paying for her time. She gets to keep her equity without sacrificing her vertebrae. Everyone wins except the people who thought executive announcements were tradeable catalysts.
Turns out you can't optimize your way out of biology.
Photo by Jonathan Kemper on Unsplash
Leave a Comment